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Abstract
Background: Dermatomyositis is an idiopathic connective tissue disease characterized by specific cutaneous
findings and inflammatory lesions in the muscle biopsy. An association between dermatomyositis and malignancy,
including breast, ovarian, lung and colon cancer was recognized many years ago, with an incidence of malignancy
in approximately 20 % of cases. Dermatomyositis is hypothesized to be an autoimmune reaction against factors or
hormones secreted by the tumor; however, the exact autoimmune mechanism of the disease pathogenesis
remains unknown.
Case presentation: Here we report a case of a woman with dermatomyositis who was diagnosed with lung
adenocarcinoma in the setting of weight loss, progressive fatigue and muscle weakness. A 43-year-old Caucasian
woman was referred to our hospital by her physician for suspected contact dermatitis since she described mild
itching sensations in her arms and legs as her major symptom. A physical examination revealed erythematous
papular lesions over her metacarpophalangeal and proximal interphalangeal joints together with a periungual
involvement with redness, hyperkeratosis and capillary telangiectasia along the distal nailfolds on her hands. She
was unaware of these features and they did not seem to bother her. A thorough examination of her medical
history, however, revealed more symptoms. Pain and weakness in the muscles of her proximal extremities and neck
flexor muscles led to difficulty in raising her arms and climbing stairs. At the same time she experienced swallowing
difficulties and reported an uncharacteristic weight loss of 10 kg in the last 3 months. The results of laboratory tests
showed increased values of serum creatine kinase and myoglobin. An electromyogram, a skin biopsy and a muscle
biopsy confirmed the diagnosis of dermatomyositis. A computed tomography of her thorax showed a nodular
mass in the upper lobe of her right lung. A histological examination of the lung biopsy showed an
adenocarcinoma of moderate differentiation. She was diagnosed with paraneoplastic dermatomyositis as the first
sign of a lung adenocarcinoma.
Conclusions: Our case report highlights the importance of a thorough search for underlying malignancy in
patients with dermatomyositis even if dermatomyositis has a mild appearance or a discrete skin manifestation.
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Background
Dermatomyositis is an idiopathic inflammatory disease
that is caused by an autoimmune reaction against skin
and muscles. Viral infections, drugs or malignancy are
the most commonly suggested trigger factors that may
lead to an immune response. Dermatomyositis has typ-
ical cutaneous features and can appear with or without
an inflammatory myositis.
The most common skin manifestations are an ery-
thema over the face, neck, and upper trunk known as
“neckline V sign” and slightly elevated erythematous
papules located on the metacarpophalangeal and prox-
imal interphalangeal joints, called “Gottron’s papules”
which are found in 60 to 80 % of patients. A purple-red
discoloration of the upper eyelids with or without associ-
ated eyelid edema may be present. Nail changes such as
capillary telangiectasia along the distal nailfold, periun-
gual erythema, and hyperkeratosis are common and, al-
though usually ignored by the patients, can be a
prodromal sign of dermatomyositis. More rarely calcino-
sis or hyperkeratotic lesions on the fingers known as
“Mechanic’s hand” appear.
Other cutaneous symptoms include photosensitivity
and pruritus [1]. The muscle symptoms consist of mild
to severe weakness of the proximal muscles, followed by
pain in one third of cases. These patients have difficul-
ties raising their arms or climbing stairs. Muscle cramps
and diffuse unexplained fatigue may be present as well.
Dysphagia, weight loss, or dyspnea may appear over time
and are usually signs of disease progression or under-
lying malignancy. The clinical presentation of dermato-
myositis and the severity of clinical symptoms vary from
patient to patient. There is no specific sequence of the
symptoms and not all of them have to be present in
order for the diagnosis to be verified. Dermatomyositis
may also have atypical manifestations or appear in an
incomplete form.
Case presentation
A 43-year-old Caucasian woman presented to our clinic
with a mild itching sensation in her arms and legs.
She was referred by her physician for contact eczema.
A physical examination revealed erythematous papular
lesions over her metacarpophalangeal and proximal in-
terphalangeal joints (Fig. 1) together with a periungual
involvement with redness, hyperkeratosis, and capillary
telangiectasia along the distal nailfolds on both her
hands (Fig. 2). No other skin findings such as heliotrope
rash or erythema on the extensor surface of her extrem-
ity joints were present.
She complained about pain and weakness in the mus-
cles of her proximal extremities and neck flexor muscles
with difficulty raising her arms and climbing stairs. At
the same time she experienced swallowing difficulties
and reported an uncharacteristic weight loss of 10 kg in
the last 3 months. She had a 30 pack-year history of
cigarette smoking with persistent nicotine use at the
time of presentation in our clinic. A neurological exam-
ination showed symmetrical mild proximal muscle weak-
ness. The rest of her physical examination including
auscultation of her lungs, body temperature and lymph
nodes status was normal.
The laboratory findings revealed elevated serum levels
of myoglobin 397 μg/l (normal range 25 to 58), creatine
phosphokinase (CK) 881 IU/L (normal range 0 to 145
IU/L) and aldolase 11.8 U/l (normal range up to 7.6 U/
l). Her liver enzymes were slightly elevated as were as-
partate transaminase (AST) 69 U/l (normal range up to
31 U/l) and alanine transaminase (ALT) 50 U/l (normal
range up to 34 U/l). Antinuclear antibody (ANA 1/160)
was weakly positive while extractable nuclear antigens
(ENAs) including anti-Jo-1 antibody were negative.
Other laboratory parameters such as C-reactive protein
Fig. 1 Erythematous papular lesions over the metacarpophalangeal
and proximal interphalangeal joints (Gottron’s papules), as well as
periungual erythema and hyperkeratosis along the distal nailfolds on
both hands of our patient
Fig. 2 Periungual erythema and capillary telangiectasia along the
distal nailfolds on both hands of our patient
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(CRP) and lactate dehydrogenase (LDH) were normal. A
histopathologic examination of the skin/muscle biopsy
showed vacuolar degeneration of the basal membrane
with perivascular inflammatory infiltration together with
a lymphohistiocytic infiltration. In addition, an extensive
mucin deposition in her dermis and linear atrophy of
her muscle layer were detected. The morphologic fea-
tures were compatible with dermatomyositis. An electro-
myogram and magnetic resonance imaging (MRI) of the
muscles of her extremities showed a symmetric moder-
ate myopathy mainly of proximal muscles which con-
firmed the diagnosis of dermatomyositis. A chest X-ray
showed an unspecific pulmonary nodule in the upper
field of her right lung. Computed tomography (CT) of
her chest revealed a nodule of 20×22 mm in her right
upper pulmonary field without mediastinal or axillar
lymphadenopathy (Fig. 3). A CT-guided biopsy of the
lung nodule revealed a lung adenocarcinoma of moder-
ate differentiation. After diagnosis of the lung tumor was
made, she underwent a thorough screening including
CT of her abdomen and MRI of her head/neck in order
to exclude other tumors, lymph metastases or organ me-
tastases. Furthermore we performed an endoscopy of
her upper digestive tract and a gynecological control to
exclude any other types of cancer. All of them were
negative. Her pulmonary function tests and echocardiog-
raphy were normal as well.
She was given a presumed diagnosis of a lung adeno-
carcinoma with clinical manifestations of paraneoplastic
dermatomyositis. No metastatic lesions were found, and
there were no abdominal or cerebral abnormalities. A
corticosteroid treatment with prednisolone 1 mg/kg/day
was administered. In the absence of cardiologic or
anesthesiologic contraindications she was assessed to be
eligible for surgery. She underwent a right upper lobec-
tomy. The histopathology showed a moderately differen-
tiated adenocarcinoma that was pathologically staged as
T1b N0 M0. In the postoperative period, she presented
partial improvement of her skin lesions, muscle weak-
ness and dysphagia.
Discussion
Dermatomyositis is an idiopathic inflammatory disease
which affects muscles and skin and is characterized by
skin rash and inflammation. Skin manifestations in-
clude erythema over the face, neck and upper trunk
known as “neckline V sign”, erythema on the extensor
surface of extremity joints, erythematous papules lo-
cated on the metacarpophalangeal and proximal interpha-
langeal joints, called “Gottron’s papules” or purple-red
discoloration of the upper eyelids usually associated with
eyelid edema “heliotrope sign”. Typical nail disorders in-
clude capillary telangiectasia along the distal nailfolds and
periungual erythema. Photosensitivity and pruritus have
also been described in patients with dermatomyositis. Cre-
atine kinase elevation, abnormalities in an electromyo-
gram and inflammatory lesions in skin and muscle biopsy
are typical findings [2]. The hallmarks of classic dermato-
myositis include skin manifestations, proximal muscle
weakness and laboratory data showing muscle inflamma-
tion. The entity dermatomyositis sine myositis has already
been described and is known as amyopathic dermatomyo-
sitis. It is thought to concern approximately 20 % of pa-
tients with dermatomyositis [3] and is associated with a
risk for rapidly progressive fatal interstitial lung disease
[4]. However, the entity dermatomyositis sine dermatitis
has rarely been reported and little literature exists to sup-
port this variant [5].
Our patient was admitted to our clinic of dermatology
for exclusion of contact allergy by her physician, because
of an itching sensation involving her arms and legs. A
thorough physical examination revealed light elevated
erythematous papular lesions over her metacarpophalan-
geal and proximal interphalangeal joints and nail
changes such as periungual erythema and capillary tel-
angiectasia along the distal nailfolds on both hands,
which were of no subjective clinical significance for our
patient. Other typical clinical features of dermatomyo-
sitis such as heliotrope rash or erythema on the extensor
surface of extremity joints were absent. Since respective
clinical signs raised a suspicion of dermatomyositis we
intensified our examination which additionally revealed
pain and proximal muscle weakness, swallowing difficul-
ties and an uncharacteristic weight loss of 10 kg in the
last 3 months. As a sudden presentation of dermatomyo-
sitis may be of paraneoplastic origin we performed fur-
ther testing in order to exclude malignancy.
An association between dermatomyositis and malig-
nancy was described many years ago. Approximately 15
to 20 % of adult patients with dermatomyositis present
with cancer at the time of the diagnosis or at some point
Fig. 3 Computed tomography of the patient’s chest showing a
speculated nodule in the upper field of her right lung
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during the follow-up [6]. Chow et al. [7] suggested that
the risk of malignancy is higher in the first year after the
diagnosis of dermatomyositis and reduces gradually over
the following years. Chen et al. [8] showed that the risk
of malignancy in patients with dermatomyositis is higher
during the first 5 years after the diagnosis. Compared to
the risk of malignancy in the general population, the in-
creased risk of malignancy in patients with dermatomyo-
sitis remains higher through all years of follow-up [7, 8].
In a retrospective analysis of 618 patients with dermato-
myositis, 198 (32 % of the patients) had cancer. In 115
cases (19 % of the patients) malignancy was found after
the diagnosis of dermatomyositis. In 83 cases (13 % of
the patients) dermatomyositis and cancer were diag-
nosed concomitantly. A similar correlation was shown
by Fujita et al. [9] concerning lung cancer. Despite the
fact that a majority of malignancies are diagnosed after
dermatomyositis, the tumor may be diagnosed before or
at the same time as the dermatomyositis, as in our case.
The most common types of cancer associated with
paraneoplastic dermatomyositis are ovary, lung, pancre-
atic, stomach, colorectal cancer or non-Hodgkin lymph-
oma with a prevalence of 6 to 45 % of patients [10].
Among them, ovary cancer has the highest incidence
worldwide [10, 11]. For all types of cancer, however, the
risk of malignancy after a diagnosis of dermatomyositis
is increased three times [10].
Although the pathogenetic mechanism of dermato-
myositis related to underlying malignancy remains
unclear, there are some hypotheses which suggest the
manifestation of dermatomyositis as a result of an im-
mune disorder, an immunologic response, a substance
secretion by neoplastic cells or as a response to newly
presented tumor-associated antigens. The symptoms of
dermatomyositis vary in severity and number and usu-
ally precede the diagnosis of malignancy.
Sterzt reported a paraneoplastic dermatomyositis with
coexisting stomach cancer for the first time in 1916 and
Kankeleit described a correlation with breast cancer at
the same time. Andreev [12] showed that dermatomyo-
sitis often coexists with lung cancer some years later,
although only a few reports are available to confirm this
statement.
Lung cancer can be divided into two categories:
small cell carcinoma and non-small cell carcinoma
with diverse clinical manifestations depending on the
localization, the infiltration of co-structures, the me-
tastases and the paraneoplastic manifestations. On
histological examination, it can be classified in four
categories: squamous cell carcinoma, adenocarcinoma,
large cell carcinoma and small cell carcinoma [13].
Hypertrophic osteopathy has been described as the
most common paraneoplastic syndrome associated
with lung cancer [14].
There are data that suggest that the presence of derm-
atomyositis is a paraneoplastic manifestation of lung
cancer. However, a coexistence with a lung adenocarcin-
oma is rather rare. Paraneoplastic dermatomyositis has a
higher incidence in cases of small cell carcinoma,
followed by squamous cell carcinoma and adenocarcin-
oma [9]. Among the four histological types of lung can-
cer, adenocarcinoma is the one most commonly found
in non-tobacco smokers and women. It is characterized
by its peripheral location and a worse prognosis caused
by the early appearance of metastases [15].
Our patient, however, was a woman who was a
cigarette smoker which differs from the abovementioned
data given from the literature. She had an unusual mani-
festation of a lung adenocarcinoma with a mild dermato-
myositis as a prodromal sign of her tumor disease.
Fortunately, because of the early diagnosis of cancer, she
had no metastases. Her paraneoplastic dermatomyositis
presented in a rather mild form. Her papular lesions and
nail disorders were the only typical signs in such a mild
form and she was unaware of them. Other typical skin
manifestations such as heliotropic rash and erythema of
the upper trunk, neck and arms were absent. In this case
report we showed that even if the complete clinical
image of classic dermatomyositis is not present there is
a high risk of an underlying malignancy.
Our patient additionally complained about persisting
pruritus as her major symptom leading to her initial
consultation with her physician before coming to our
clinic. Although pruritus has already been described as a
clinical feature of dermatomyositis it remains a low-yield
symptom concerning the diagnosis and is rather under-
estimated [16]. Dundley et al. [17] showed that pruritus
can severely affect the quality of life of patients with
dermatomyositis. In our case report it is remarkable that
our patient described pruritus as one of her major symp-
toms, when asked. Therefore, the management of prur-
itus may also be included in the therapeutical concept in
dermatomyositis.
As the pathophysiology of paraneoplastic dermato-
myositis remains unclear, no standard treatment regimen
has been established yet. Therapy with high-dose corti-
costeroids is suggested as the first-line therapy. In pa-
tients with no therapeutical response to corticosteroids
an immunosuppressive therapy with azathioprine, cyclo-
sporine, mycophenolate or methotrexate may lead to an
improvement of symptoms and better disease control.
Therapy with human immunoglobulins administered
intravenously (IVIG) is suggested as second-line therapy
[18]. In any case, the control of the underlying malig-
nancy is independent of the severity of dermatomyositis
and remains the most important part of the therapy as
dermatomyositis improves or resolves after cancer treat-
ment. As patients with a tumor and dermatomyositis
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may have a worse prognosis and quality of life, early
diagnosis and treatment of this paraneoplastic disease is
highly important.
Conclusions
Our case report illustrates that paraneoplastic dermato-
myositis, even in a mild form without all of the typical
skin manifestations, may appear as a prodromal sign of
malignancy. As the prognosis of paraneoplastic dermato-
myositis depends on the underlying malignancy, an early
recognition and awareness of this entity is not only
important for a prompt diagnosis of the tumor but also for
a better prognosis and quality of life for these patients.
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